Long-term changes in the aggregation state and toxic effects of β- amyloid injected into the rat brain

Neuroscience

Volumn 87, Issue 2, 1998, Pages 349-357

  Giovannelli, L ^a   Scali, C ^a   Faussone Pellegrini, M S ^a   Pepeu, G ^a   Casamenti, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer; ChAT immunoreactivity; Neurodegeneration; Nucleus basalis; Rat; Toxicity

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; NEUROLOGIC DISEASE; NONHUMAN; NUCLEUS ACCUMBENS; OLIVARY NUCLEUS; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; AMYLOID BETA-PROTEIN; ANIMALS; BASAL GANGLIA; BRAIN; CELL AGGREGATION; CHOLINE O-ACETYLTRANSFERASE; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 0032551649     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00169-9     Document Type: Article

References (44)

1. Abe E., Casamenti F., Giovannelli L., Scali C., Pepeu G. Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res. 636:1994;162-164.
2. Araujo D. M., Cotman C. W. Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 569:1992;141-145.
3. Arendt T., Bruckner M. K., Krell T., Pagliusi S., Kruska L., Heumann R. Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury - I. Degeneration and plastic response of basal forebrain neurons. Neuroscience. 65:1995;633-645.
4. Arendt T., Bruckner M. K., Krell T., Pagliusi S., Kruska L., Heumann R. Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury - II. Reactive expression of the nerve growth factor gene in astrocytes. Neuroscience. 65:1995;647-659.
5. Behl C., Davis J. B., Klier F. G., Schubert D. Amyloid β peptide induces necrosis rather than apoptosis. Brain Res. 645:1994;253-264.
6. Behl C., Davis J. B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
7. Benzi G., Moretti A. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol. Aging. 16:1995;661-674.
8. Busciglio J., Lorenzo A., Yankner B. A. Methodological variables in the assessment of β amyloid neurotoxicity. Neurobiol. Aging. 13:1992;609-612.
9. Busciglio J., Lorenzo A., Yeh J., Yankner B. A. β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 14:1995;879-888.
10. Butterfield D. A., Hensley K., Harris M., Mattson M., Carney J. β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. biophys. Res. Commun. 200:1994;710-715.
11. Cai X., Golde T. E., Younkin S. G. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science. 259:1993;514-516.
12. Casamenti F., Scali C., Pepeu G. Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study. Eur. J. Pharmac. 194:1991;11-16.
13. Clemens J. A., Stephenson D. T. Implants containing β-amyloid protein are not neurotoxic to young and old rat brain. Neurobiol. Aging. 13:1992;581-586.
14. El Khoury J., Hickman S. E., Thomas C. A., Cao L., Silverstein S. C., Loike J. D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature. 382:1996;716-719.
15. Emre M., Geula C., Ransil B. J., Mesulam M. M. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain. Neurobiol. Aging. 13:1992;553-559.
16. Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O., Tagliavini F. Neurotoxicity of a prion protein fragment. Nature. 362:1993;543-546.
17. Frautschy S. A., Baird A., Cole G. M. Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. natn. Acad. Sci. U.S.A. 88:1991;8362-8366.
18. Games D., Khan K. M., Soriano F. G., Davis D. L., Bryant K., Lieberburg I. Lack of Alzheimer pathology after β-amyloid protein injections in the rat. Neurobiol. Aging. 13:1992;569-576.
19. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
20. Giovannelli L., Casamenti F., Scali C., Bartolini L., Pepeu G. Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience. 66:1995;781-792.
21. Hefti F., Hartikka J., Knusel B. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol. Aging. 10:1989;515-533.
22. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-106.
23. Joachim C. L., Selkoe D. J. The seminal role of β-amyloid in the pathogenesis of Alzheimer disease. Alz. Dis. assoc. Disord. 6:1992;7-34.
24. Koh J., Yang L. L., Cotman C. W. β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:1990;315-320.
25. Kowall N. W., Beal M. F., Busciglio J., Duffy L. K., Yankner B. A. An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance P. Proc. natn. Acad. Sci. U.S.A. 88:1991;7247-7251.
26. Kowall N. W., McKee A. C., Yankner B. A., Beal M. F. In vivo neurotoxicity of beta-amyloid β(1-40) and the β(25-35) fragment. Neurobiol. Aging. 13:1992;537-542.
27. Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J., Cotman C. W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. natn. Acad. Sci. U.S.A. 90:1993;7951-7955.
28. Lorenzo A., Yankner B. A. β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo Red. Proc. natn. Acad. Sci. U.S.A. 91:1994;12243-12247.
29. Lorenzo A., Razzaboni B., Weir G. C., Yankner B. A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 368:1994;756-760.
30. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R. E. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
31. Mattson M. P. Free radicals and disruption of neuronal ion homeostasis in AD: a role for amyloid β-peptide? Neurobiol. Aging. 16:1995;679-682.
32. Paresce D. M., Ghosh R. N., Maxfield F. R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron. 17:1996;553-565.
33. Paxinos G. and Watson G. (1982) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
34. Pike C. J., Walenecwicz A. J., Glabe C. G., Cotman C. W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
35. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., Cotman C. W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
36. Podlisny M. B., Stephenson D. T., Frosch M. P., Tolan D. R., Lieberburg I., Clemens J. A., Selkoe D. J. Synthetic amyloid β-protein fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiol. Aging. 13:1992;561-567.
37. Puchtler H., Sweat F., Levine M. On the binding of Congo Red by amyloid. J. Histochem. Cytochem. 10:1962;355-364.
38. Selkoe D. J. Normal and abnormal biology of the β-amyloid precursor protein. A. Rev. Neurosci. 17:1994;489-517.
39. Shin R., Ogino K., Kondo A., Saido T. C., Trojanowski J. Q., Kitamoto T., Tateishi J. Amyloid β-protein (Aβ)1-40 but not Aβ1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain. J. Neurosci. 17:1997;8187-8193.
40. Snow A. D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W. A., Morgan D. G. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain. Neuron. 12:1994;219-234.
41. Stein-Behrens B., Adams K., Yeh M., Sapolski R. Failure of β-amyloid protein fragment 25-35 to cause hippocampal damage in the rat. Neurobiol. Aging. 13:1992;577-579.
42. Yankner B. A., Duffy L. K., Kirschner D. A. Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
43. Weldon D. T., Maggio J. E., Mantyh P. W. New insights into the neuropathology and cell biology of Alzheimer's disease. Geriatrics. 52(2):1997;S13-16.
44. Winkler J., Connor D. J., Frautschy S. A., Behl C., Waite J. J., Cole G., Thal L. J. Lack of long-term effects after β-amyloid protein injections in rat brain. Neurobiol. Aging. 15:1994;601-607.